| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 19:25:17 UTC |
|---|
| Update Date | 2021-09-26 23:14:56 UTC |
|---|
| HMDB ID | HMDB0258188 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide |
|---|
| Description | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide, also known as 3',5'-dichloro-2,4'-dihydroxybenzanilide or N-salicylo-(2,6-dichloro-4-aminophenol), belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. Based on a literature review a small amount of articles have been published on N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-(3,5-dichloro-4-hydroxyphenyl)-2-hydroxybenzamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | OC1=CC=CC(=C1)C(=O)NC1=CC(Cl)=C(O)C(Cl)=C1 InChI=1S/C13H9Cl2NO3/c14-10-5-8(6-11(15)12(10)18)16-13(19)7-2-1-3-9(17)4-7/h1-6,17-18H,(H,16,19) |
|---|
| Synonyms | | Value | Source |
|---|
| N-(3,5-Dichloro-4-hydroxyphenyl)-3-hydroxybenzene-1-carboximidate | HMDB | | 3',5'-Dichloro-2,4'-dihydroxybenzanilide | HMDB | | N-Salicylo-(2,6-dichloro-4-aminophenol) | HMDB |
|
|---|
| Chemical Formula | C13H9Cl2NO3 |
|---|
| Average Molecular Weight | 298.12 |
|---|
| Monoisotopic Molecular Weight | 296.9959486 |
|---|
| IUPAC Name | N-(3,5-dichloro-4-hydroxyphenyl)-3-hydroxybenzamide |
|---|
| Traditional Name | N-(3,5-dichloro-4-hydroxyphenyl)-3-hydroxybenzamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC1=CC=CC(=C1)C(=O)NC1=CC(Cl)=C(O)C(Cl)=C1 |
|---|
| InChI Identifier | InChI=1S/C13H9Cl2NO3/c14-10-5-8(6-11(15)12(10)18)16-13(19)7-2-1-3-9(17)4-7/h1-6,17-18H,(H,16,19) |
|---|
| InChI Key | ZYIZNUYMGIICGZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Anilides |
|---|
| Direct Parent | Benzanilides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzanilide
- Benzoic acid or derivatives
- Benzamide
- 2-chlorophenol
- 2-halophenol
- 1,3-dichlorobenzene
- Benzoyl
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Halobenzene
- Chlorobenzene
- Aryl halide
- Aryl chloride
- Secondary carboxylic acid amide
- Carboxamide group
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 6.25 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.732 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.19 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2273.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 430.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 161.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 269.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 334.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 675.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 687.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 153.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1274.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 475.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1555.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 476.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 427.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 519.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 233.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 138.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC(C(=O)N(C2=CC(Cl)=C(O[Si](C)(C)C)C(Cl)=C2)[Si](C)(C)C)=C1 | 2645.3 | Semi standard non polar | 33892256 | | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC(C(=O)N(C2=CC(Cl)=C(O[Si](C)(C)C)C(Cl)=C2)[Si](C)(C)C)=C1 | 2579.6 | Standard non polar | 33892256 | | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide,3TMS,isomer #1 | C[Si](C)(C)OC1=CC=CC(C(=O)N(C2=CC(Cl)=C(O[Si](C)(C)C)C(Cl)=C2)[Si](C)(C)C)=C1 | 2706.0 | Standard polar | 33892256 | | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC(C(=O)N(C2=CC(Cl)=C(O[Si](C)(C)C(C)(C)C)C(Cl)=C2)[Si](C)(C)C(C)(C)C)=C1 | 3440.3 | Semi standard non polar | 33892256 | | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC(C(=O)N(C2=CC(Cl)=C(O[Si](C)(C)C(C)(C)C)C(Cl)=C2)[Si](C)(C)C(C)(C)C)=C1 | 3186.5 | Standard non polar | 33892256 | | N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=CC(C(=O)N(C2=CC(Cl)=C(O[Si](C)(C)C(C)(C)C)C(Cl)=C2)[Si](C)(C)C(C)(C)C)=C1 | 3009.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-7920000000-159eada60b5a92a58031 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-(3,5-Dichloro-4-hydroxyphenyl)-2-hydroxybenzamide GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
|
|---|